000 | 01965 a2200565 4500 | ||
---|---|---|---|
005 | 20250516075255.0 | ||
264 | 0 | _c20120517 | |
008 | 201205s 0 0 eng d | ||
022 | _a1539-2864 | ||
024 | 7 |
_a10.1097/IAE.0b013e31822c296b _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWoo, Se Joon | |
245 | 0 | 0 |
_aBilateral same-day intravitreal injections using a single vial and molecular bacterial screening for safety surveillance. _h[electronic resource] |
260 |
_bRetina (Philadelphia, Pa.) _cApr 2012 |
||
300 |
_a667-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAngiogenesis Inhibitors _xadministration & dosage |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xadministration & dosage |
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadministration & dosage |
650 | 0 | 4 |
_aBacteria _xisolation & purification |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Contamination |
650 | 0 | 4 |
_aEye Infections, Bacterial _xdiagnosis |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntravitreal Injections _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPolymerase Chain Reaction _xmethods |
650 | 0 | 4 |
_aRNA, Ribosomal, 16S _xanalysis |
650 | 0 | 4 | _aRanibizumab |
650 | 0 | 4 |
_aRetinal Diseases _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 |
_aTriamcinolone _xadministration & dosage |
700 | 1 | _aHan, Jeong Mo | |
700 | 1 | _aAhn, Jeeyun | |
700 | 1 | _aHeo, Jang Won | |
700 | 1 | _aYu, Hyeong Gon | |
700 | 1 | _aChung, Hum | |
700 | 1 | _aSong, Junghan | |
700 | 1 | _aPark, Kyoung Un | |
700 | 1 | _aPark, Kyu Hyung | |
773 | 0 |
_tRetina (Philadelphia, Pa.) _gvol. 32 _gno. 4 _gp. 667-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/IAE.0b013e31822c296b _zAvailable from publisher's website |
999 |
_c21519683 _d21519683 |